Marker Therapeutics (MRKR) Depreciation and Depletion (2019 - 2023)
Marker Therapeutics (MRKR) reported Depreciation and Depletion of $800000.0 for Q1 2023, up 33.33% year-over-year from $600000.0 in Q1 2022, and up 157.14% quarter-over-quarter from -$1.4 million in Q4 2022.
Marker Therapeutics (MRKR) Depreciation and Depletion (2019 - 2023) Analysis & Trends
Marker Therapeutics (MRKR) has 5 years of Depreciation and Depletion data on file, last reported at $800000.0 in Q1 2023.
- Depreciation and Depletion for Q1 2023 came in at $800000.0, up 33.33% year-over-year; the trailing twelve-month figure through Mar 2023 was $800000.0 (down 63.64% YoY), and the FY2022 annual result was $600000.0, down 71.43% from the prior year.
- Depreciation and Depletion rose to $800000.0 in Q1 2023 per MRKR's latest filing, from -$1.4 million in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $800000.0 in Q3 2022 and troughed at -$1.4 million in Q4 2022.
- A 5-year average of $237058.8 and a median of $200000.0 in 2020 frame the typical range for Depreciation and Depletion.
- The sharpest annual moves came in 2021 and 2022: Depreciation and Depletion soared 1566.67% in 2021, then slumped 380.0% in 2022.
- A 5-year view of Depreciation and Depletion shows it stood at $30000.0 in 2019, then jumped by 566.67% to $200000.0 in 2020, then surged by 150.0% to $500000.0 in 2021, then tumbled by 380.0% to -$1.4 million in 2022, then jumped by 157.14% to $800000.0 in 2023.
- Business Quant data shows MRKR's Depreciation and Depletion at $800000.0 in Q1 2023, -$1.4 million in Q4 2022, and $800000.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Marker Therapeutics | 28.20 Mn | 28.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 800,000.00 |
| Mar 31, 2023 | 800,000.00 |
| Dec 31, 2022 | -1.40 Mn |
| Dec 31, 2022 | -1.40 Mn |
| Sep 30, 2022 | 800,000.00 |
| Sep 30, 2022 | 800,000.00 |
| Jun 30, 2022 | 600,000.00 |
| Jun 30, 2022 | 600,000.00 |
| Mar 31, 2022 | 600,000.00 |
| Mar 31, 2022 | 600,000.00 |
| Dec 31, 2021 | 500,000.00 |
| Dec 31, 2021 | 500,000.00 |
| Sep 30, 2021 | 600,000.00 |
| Sep 30, 2021 | 600,000.00 |
| Jun 30, 2021 | 500,000.00 |
| Jun 30, 2021 | 500,000.00 |
| Mar 31, 2021 | 500,000.00 |
| Mar 31, 2021 | 500,000.00 |
| Dec 31, 2020 | 200,000.00 |
| Dec 31, 2020 | 200,000.00 |